Neoepitope detection of disease using protein arrays
US10302646B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2013 |
| Grant date | May 28, 2019 |
| Priority date | — |
| Expiry date | Feb 28, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/36
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A biosensor for use in detecting the presence of diseases, the biosensor comprising a detector for detecting a presence of at least one marker indicative of a specific disease. A method of determining efficacy of a pharmaceutical for treating a disease or staging disease by administering a pharmaceutical to a sample containing markers for a disease, detecting the amount of at least one marker of the disease in the sample, and analyzing the amount of the marker in the sample, whereby the amount of marker correlates to pharmaceutical efficacy or disease stage. Markers for gynecological disease. An immune-imaging agent comprising labeled antibodies, whereby the labeled antibodies are isolated and reactive to proteins overexpressed in vivo. Informatics software for analyzing the arrays, the software including analyzing means for analyzing the arrays.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.